◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

PRIVIA HEALTH GROUP, INC.

CIK: 1759655 SIC: 8000
$2.12B
Revenue
$22.92M
Net Income
-
Gross Margin
1.61%
Op. Margin
$123.25M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 5 of 5 annual reports available (2021 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
+ Total Revenue $2.12B $2.12B $1.74B $1.66B $1.36B $966.22M
Revenue Growth % 0.0% 22.3% 4.7% 22.2% 40.4% nan%
Operating Expenses $2.09B $2.09B $1.72B $1.64B $1.38B $1.18B
+ Operating Income $34.23M $34.23M $16.98M $20.65M $-19.12M $-217.44M
Operating Margin % 1.6% 1.6% 1.0% 1.2% -1.4% -22.5%
Interest Expense $375.00K $251.00K $285.00K $40.00K $713.00K $888.00K
Other Income/Expense $9.70M $9.70M $10.89M $8.37M $542.00K -
Income Before Tax $43.94M $43.94M $27.87M $29.02M $-18.58M $-218.51M
Income Tax Expense $14.21M $14.21M $10.83M $7.99M $-6.52M $-27.86M
+ Net Income $22.92M $22.92M $14.38M $23.08M $-8.59M $-188.23M
Net Margin % 1.1% 1.1% 0.8% 1.4% -0.6% -19.5%
Basic EPS 0.19 0.19 0.12 0.20 -0.08 -1.83
Diluted EPS 0.17 0.18 0.11 0.19 -0.08 -1.83
Basic Shares Outstanding - 122.2M 119.4M 116.7M 110.7M 103.0M
Diluted Shares Outstanding - 128.9M 125.6M 124.7M 110.7M 103.0M
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Cash & Cash Equivalents $479.69M $491.15M $389.51M $347.99M $320.58M
Accounts Receivable $400.90M $316.18M $290.77M $189.60M $117.40M
Other Current Assets $30.41M $27.50M $20.52M $14.37M $8.70M
Total Current Assets $911.00M $834.82M $700.80M $551.96M $446.68M
Property Plant & Equipment $504.00K $1.24M $2.33M $3.39M $4.50M
Goodwill $209.84M $141.62M $138.75M $126.94M $127.94M
Intangible Assets $215.92M $109.81M $107.63M $57.39M $59.74M
Other Non-current Assets $21.04M $17.09M $8.58M $4.68M $4.52M
Total Assets $1.37B $1.14B $999.90M $792.81M $686.37M
Accounts Payable $7.97M $9.76M - - -
Total Current Liabilities $568.52M $449.15M $386.95M $264.27M $190.46M
Other Non-current Liabilities $2.58M $153.00K $313.00K $1.00M $3.00M
Total Liabilities $578.43M $452.34M $392.51M $273.76M $236.19M
Common Stock $1.24M $1.20M $1.18M $1.15M $1.08M
Retained Earnings $-156.31M $-179.23M $-193.61M $-216.69M $-208.11M
Total Stockholders Equity $737.22M $635.18M $561.44M $499.09M $426.87M
Total Liabilities & Equity $1.37B $1.14B $999.90M $792.81M $686.37M
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Net Income $22.92M $22.92M $14.38M $23.08M $-8.59M $-188.23M
Depreciation & Amortization $9.91M $9.91M $7.27M $6.53M $4.57M $2.46M
Stock-based Compensation $125.50M $71.07M $56.68M $37.10M $67.36M $253.53M
Deferred Income Tax $15.26M $10.87M $8.82M $7.46M $-7.00M $-28.41M
Change in Receivables $230.71M $36.67M $19.82M $96.88M $72.20M $14.64M
Change in Payables $-6.71M $14.82M $19.91M $4.99M $6.85M $1.26M
Operating Cash Flow $123.25M $163.40M $109.28M $80.78M $47.20M $55.06M
Capital Expenditure - - - $113.00K $104.00K $547.00K
Acquisitions $269.43M $180.37M $6.96M $42.86M - $32.23M
Investing Cash Flow $-270.63M $-181.57M $-11.98M $-42.97M $-104.00K $-32.77M
Financing Cash Flow $13.07M $6.70M $4.33M $3.71M $-19.68M $213.66M
Net Change in Cash $-134.30M $-11.46M $101.64M $41.52M $27.41M $235.94M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $580.42M - $1.58B -
Operating Expenses $566.02M - $1.56B -
Operating Income $14.40M - $22.96M -
Interest Expense - - $188.00K -
Other Income/Expense $2.27M - $7.61M -
Income Before Tax $16.67M - $30.57M -
Income Tax Expense $6.87M - $11.43M -
Net Income $6.86M $4.64M $13.77M -
Basic EPS 0.06 - 0.11 -
Diluted EPS 0.05 - 0.11 -
Basic Shares Outstanding $122.77M - $121.84M -
Diluted Shares Outstanding $128.78M - $128.39M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $441.35M $491.15M
Accounts Receivable $499.04M $316.18M
Other Current Assets $30.53M $27.50M
Total Current Assets $970.93M $834.82M
Property Plant & Equipment $662.00K $1.24M
Goodwill $172.22M $141.62M
Intangible Assets $167.54M $109.81M
Other Non-current Assets $16.93M $17.09M
Total Assets $1.35B $1.14B
Total Current Liabilities $582.91M $449.15M
Other Non-current Liabilities $1.64M $153.00K
Total Liabilities $588.23M $452.34M
Common Stock $1.23M $1.20M
Retained Earnings $-165.46M $-179.23M
Total Stockholders Equity $709.12M $635.18M
Total Liabilities & Equity $1.35B $1.14B
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $6.86M $4.64M $13.77M -
Depreciation & Amortization $2.77M - $7.25M -
Stock-based Compensation - - $55.62M -
Deferred Income Tax - - $9.34M -
Change in Receivables - - $176.54M -
Change in Payables - - $2.68M -
Operating Cash Flow - - $35.90M -
Acquisitions - - $89.06M -
Investing Cash Flow - - $-90.26M -
Financing Cash Flow - - $4.56M -
Net Change in Cash - - $-49.80M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...